Literature DB >> 18980340

Nuclear magnetic resonance spectroscopy as a quantitative tool to determine the concentrations of biologically produced metabolites: implications in metabolites in safety testing.

Robert Espina1, Linning Yu, Jianyao Wang, Zeen Tong, Sarvesh Vashishtha, Rasmy Talaat, JoAnn Scatina, Abdul Mutlib.   

Abstract

Nuclear magnetic resonance (NMR) spectroscopy has traditionally been considered as an indispensable tool in elucidating structures of metabolites. With the advent of Fourier transform (FT) spectrometers, along with improvements in software and hardware (such as high-field magnets, cryoprobes, versatile pulse sequences, and solvent suppression techniques), NMR is increasingly being considered as a critical quantitative tool, despite its lower sensitivity as compared to mass spectrometry. A specific quantitative application of NMR is in determining the concentrations of biologically isolated metabolites, which could potentially be used as reference standards for further quantitative work by liquid chromatography/mass spectrometry. With the recent demands from regulatory agencies on quantitative information on metabolites, it is proposed that NMR will play a significant role in strategies aimed at addressing metabolite coverage in toxicological species. Traditionally, biologically isolated metabolites have not been considered as a way of generating "reference standards" for further quantitative work. However, because of the recent FDA guidance on safety testing of metabolites, one has to consider means of authenticating and quantitating biologically or nonbiologically generated metabolites. 1H NMR is being proposed as the method of choice, as it is able to be used as both a qualitative and a quantitative tool, hence allowing structure determination, purity check, and quantitative measurement of the isolated metabolite. In this publication, the application of NMR as a powerful and robust analytical technique in determining the concentrations of in vitro or in vivo isolated metabolites is discussed. Furthermore, to demonstrate the reliability and accuracy of metabolite concentrations determined by NMR, validation and cross-validation with gravimetric and mass spectrometric methods were conducted.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18980340     DOI: 10.1021/tx800251p

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  13 in total

1.  Meeting report: metabolites in safety testing (MIST) symposium-safety assessment of human metabolites: what's REALLY necessary to ascertain exposure coverage in safety tests?

Authors:  Hongying Gao; Abigail Jacobs; Ronald E White; Brian P Booth; R Scott Obach
Journal:  AAPS J       Date:  2013-07-03       Impact factor: 4.009

2.  Conventional liquid chromatography/triple quadrupole mass spectrometry based metabolite identification and semi-quantitative estimation approach in the investigation of in vitro dabigatran etexilate metabolism.

Authors:  Zhe-Yi Hu; Robert B Parker; Vanessa L Herring; S Casey Laizure
Journal:  Anal Bioanal Chem       Date:  2012-12-14       Impact factor: 4.142

Review 3.  Universal quantitative NMR analysis of complex natural samples.

Authors:  Charlotte Simmler; José G Napolitano; James B McAlpine; Shao-Nong Chen; Guido F Pauli
Journal:  Curr Opin Biotechnol       Date:  2013-09-14       Impact factor: 9.740

4.  Validation of a generic quantitative (1)H NMR method for natural products analysis.

Authors:  Tanja Gödecke; José G Napolitano; María F Rodríguez-Brasco; Shao-Nong Chen; Birgit U Jaki; David C Lankin; Guido F Pauli
Journal:  Phytochem Anal       Date:  2013-06-05       Impact factor: 3.373

Review 5.  Rationalization and prediction of in vivo metabolite exposures: the role of metabolite kinetics, clearance predictions and in vitro parameters.

Authors:  Justin D Lutz; Yasushi Fujioka; Nina Isoherranen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2010-09       Impact factor: 4.481

Review 6.  Quantitative 1H NMR. Development and potential of an analytical method: an update.

Authors:  Guido F Pauli; Tanja Gödecke; Birgit U Jaki; David C Lankin
Journal:  J Nat Prod       Date:  2012-04-06       Impact factor: 4.050

7.  Quantifying the metabolic activation of nevirapine in patients by integrated applications of NMR and mass spectrometries.

Authors:  Abhishek Srivastava; Lu-Yun Lian; James L Maggs; Masautso Chaponda; Munir Pirmohamed; Dominic P Williams; B Kevin Park
Journal:  Drug Metab Dispos       Date:  2010-01       Impact factor: 3.922

8.  Identification of early biomarkers during acetaminophen-induced hepatotoxicity by fourier transform infrared microspectroscopy.

Authors:  Rekha Gautam; Bhagawat Chandrasekar; Mukta Deobagkar-Lele; Srabanti Rakshit; Vinay Kumar B N; Siva Umapathy; Dipankar Nandi
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

Review 9.  Importance of purity evaluation and the potential of quantitative ¹H NMR as a purity assay.

Authors:  Guido F Pauli; Shao-Nong Chen; Charlotte Simmler; David C Lankin; Tanja Gödecke; Birgit U Jaki; J Brent Friesen; James B McAlpine; José G Napolitano
Journal:  J Med Chem       Date:  2014-10-08       Impact factor: 7.446

10.  Integration of Microfractionation, qNMR and zebrafish screening for the in vivo bioassay-guided isolation and quantitative bioactivity analysis of natural products.

Authors:  Nadine Bohni; María Lorena Cordero-Maldonado; Jan Maes; Dany Siverio-Mota; Laurence Marcourt; Sebastian Munck; Appolinary R Kamuhabwa; Mainen J Moshi; Camila V Esguerra; Peter A M de Witte; Alexander D Crawford; Jean-Luc Wolfender
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.